CausalSentinel

Protein Dossier — NRP1 (Protein kinase C-binding protein NELL1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.113 0.0351 0.00124 Inverse variance weighted 2 trans NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.113 0.0351 0.00124 Inverse variance weighted 2 cis NA
Coronary heart disease -0.0969 0.0303 0.00141 Inverse variance weighted 2 trans NA
Coronary heart disease -0.0969 0.0303 0.00141 Inverse variance weighted 2 cis NA
Primary sclerosing cholangitis 0.293 0.0949 0.00205 Inverse variance weighted 2 trans NA
Primary sclerosing cholangitis 0.293 0.0949 0.00205 Inverse variance weighted 2 cis NA
Vascular or heart problems diagnosed by doctor: Angina -0.141 0.048 0.00331 Inverse variance weighted 2 trans NA
Vascular or heart problems diagnosed by doctor: Angina -0.141 0.048 0.00331 Inverse variance weighted 2 cis NA
Myocardial infarction -0.0908 0.0311 0.0035 Inverse variance weighted 2 trans NA
Myocardial infarction -0.0908 0.0311 0.0035 Inverse variance weighted 2 cis NA
Hip osteoarthritis 0.233 0.0857 0.00661 Inverse variance weighted 2 trans NA
Hip osteoarthritis 0.233 0.0857 0.00661 Inverse variance weighted 2 cis NA
…and 204 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3214_3_2 NRP1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

176 association rows across 108 traits (135 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating NRP1 levels 8e-557 rs734186 4 GCST90860421 no MR -> candidate analysis
Neuropilin-1 levels 5e-115 rs2506150 3 GCST90248732 no MR -> candidate analysis
NRP1 protein levels 6e-57 rs111793120 12 GCST90470085 no MR -> candidate analysis
Serum levels of protein NRP1 4e-40 rs2474720 2 GCST90089072 no MR -> candidate analysis
Cerebrospinal fluid protein NRP1 levels 1e-38 rs734186 1 GCST90945026 no MR -> candidate analysis
Vertex-wise sulcal depth 2e-34 rs2506141 2 GCST90095129 no MR -> candidate analysis
Neuropilin-1 (analyte X5542.22) levels 3e-30 rs2506149 1 GCST90426380 no MR -> candidate analysis
Neuropilin-1 (analyte X3214.3) levels 4e-29 rs2506149 1 GCST90425658 no MR -> candidate analysis
Neuropilin-1 levels (NRP1.3214.3.2) 7e-28 rs2506149 1 GCST90242093 no MR -> candidate analysis
High-density lipoprotein levels 5e-27 rs3750733 1 GCST90662894 no MR -> candidate analysis
Blood protein levels 3e-25 rs2253918 2 GCST006585 no MR -> candidate analysis
High density lipoprotein cholesterol levels 1e-23 rs10827239 2 GCST90239649 no MR -> candidate analysis
…and 96 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1331 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
migraine disorder 0.561 common-variant locus no MR -> candidate analysis
obstructive sleep apnea syndrome 0.563 common-variant locus no MR -> candidate analysis
health study participation 0.55 common-variant locus no MR -> candidate analysis
mathematical ability 0.549 common-variant locus no MR -> candidate analysis
nerve plexus disorder 0.537 common-variant locus no MR -> candidate analysis
ovarian neoplasm 0.523 common-variant locus no MR -> candidate analysis
metabolic disease 0.524 common-variant locus no MR -> candidate analysis
digestive system disorder 0.497 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.497 common-variant locus no MR -> candidate analysis
Barrett esophagus 0.428 common-variant locus no MR -> candidate analysis
placenta praevia 0.407 common-variant locus no MR -> candidate analysis
corneal neovascularization 0.406 common-variant locus no MR -> candidate analysis
liver disorder 0.391 common-variant locus no MR -> candidate analysis
jaw disease 0.391 common-variant locus no MR -> candidate analysis
medical procedure 0.387 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 15 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (VEGA-NRP1)
gnomAD constraint pLI=1, LOEUF=0.435 — LoF-INTOLERANT
GWAS Catalog 108 unique SNPs / 225 rows
ClinVar 360 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance